Published in Eur J Neurol on September 01, 2007
Amyotrophic lateral sclerosis. Orphanet J Rare Dis (2009) 2.76
Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease. Health Qual Life Outcomes (2011) 1.23
Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2010) 1.05
PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions. PLoS One (2013) 0.95
A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int (2015) 0.93
Psychopathological features and suicidal ideation in amyotrophic lateral sclerosis patients. Neurol Sci (2010) 0.88
Patient-Perceived Outcomes and Quality of Life in ALS. Neurotherapeutics (2015) 0.87
A pilot study of the prevalence of psychiatric disorders in PLS and ALS. Amyotroph Lateral Scler (2010) 0.81
Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort. BMC Neurol (2015) 0.80
Efficacy of hypnosis-based treatment in amyotrophic lateral sclerosis: a pilot study. Front Psychol (2012) 0.80
Severe loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment study. Interact J Med Res (2013) 0.78
Hypnosis-based psychodynamic treatment in ALS: a longitudinal study on patients and their caregivers. Front Psychol (2015) 0.77
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study. BMJ Open (2015) 0.77
Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. NeuroRehabilitation (2015) 0.75
Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease. Neuropsychiatr Dis Treat (2015) 0.75
Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS). J Neurol Neurophysiol (2017) 0.75
Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet (1996) 4.11
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet (1992) 3.30
Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain (1992) 2.64
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis (2004) 2.29
Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (1998) 2.28
An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry (2010) 2.14
Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology (1999) 1.98
Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett (1992) 1.82
Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia (2000) 1.80
Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2002) 1.80
New VAPB deletion variant and exclusion of VAPB mutations in familial ALS. Neurology (2008) 1.76
Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. J Neurol Neurosurg Psychiatry (1996) 1.74
Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology (2009) 1.71
Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS. Neurology (2001) 1.68
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2013) 1.65
Respiratory aspects of neurological disease. J Neurol Neurosurg Psychiatry (1999) 1.61
Differential corticospinal tract degeneration in homozygous 'D90A' SOD-1 ALS and sporadic ALS. J Neurol Neurosurg Psychiatry (2011) 1.55
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet (1999) 1.54
Thalamo-frontal psychosis. Br J Psychiatry (1993) 1.53
Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology (2007) 1.52
Ethical and clinical issues in the use of home non-invasive mechanical ventilation for the palliation of breathlessness in motor neurone disease. Thorax (1999) 1.50
Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial. Neurology (2006) 1.47
EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol (2005) 1.45
Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain (2001) 1.44
Mutations in all five exons of SOD-1 may cause ALS. Ann Neurol (1998) 1.40
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group. Neurology (1998) 1.37
Familial amyotrophic lateral sclerosis. Molecular pathology of a patient with a SOD1 mutation. Neurology (1997) 1.35
Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain (2004) 1.35
A patient with reflex myoclonus and muscle rigidity: "jerking stiff-man syndrome". J Neurol Neurosurg Psychiatry (1980) 1.34
Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (1997) 1.34
Glutamate slows axonal transport of neurofilaments in transfected neurons. J Cell Biol (2000) 1.33
Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002. J Neurol Neurosurg Psychiatry (2003) 1.33
Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain (1993) 1.31
Mills' and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET. J Neurol Neurosurg Psychiatry (2005) 1.29
Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. Neurology (2006) 1.27
Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol (2005) 1.27
Coloured speech perception: is synaesthesia what happens when modularity breaks down? Perception (1993) 1.25
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET. Brain (2005) 1.24
Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia (1993) 1.23
A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology (2001) 1.22
Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum Mol Genet (1998) 1.22
Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry (1994) 1.21
Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain (1996) 1.21
Idiopathic parkinsonism treated with bromocriptine. Lancet (1975) 1.20
Comparison of starch-branching enzyme genes reveals evolutionary relationships among isoforms. Characterization of a gene for starch-branching enzyme IIa from the wheat genome donor Aegilops tauschii. Plant Physiol (2001) 1.16
Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS. J Neurol Neurosurg Psychiatry (2005) 1.16
A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II. Neurology (1996) 1.16
Reorganization of cortical blood flow and transcranial magnetic stimulation maps in human subjects after upper limb amputation. J Neurophysiol (1994) 1.15
Correlates of Quality of Life in people with motor neuron disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord (2002) 1.14
Treatment of parkinsonism with bromocriptine. Lancet (1974) 1.13
Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. Lancet (1996) 1.13
Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain (2000) 1.13
Molecular characterisation and expression of a wound-inducible cDNA encoding a novel cinnamyl-alcohol dehydrogenase enzyme in lucerne (Medicago sativa L.) Plant Mol Biol (1999) 1.12
Use of human intravenous immunoglobulin in lower motor neuron syndromes. J Neurol Neurosurg Psychiatry (1999) 1.12
Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J Cell Sci (2000) 1.10
A complex arrangement of genes at a starch branching enzyme I locus in the D-genome donor of wheat. Genome (1997) 1.10
Recent advances in amyotrophic lateral sclerosis. Curr Opin Neurol (2000) 1.09
The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study. J Neurol Neurosurg Psychiatry (2001) 1.08
Cortical selective vulnerability in motor neuron disease: a morphometric study. Brain (2004) 1.07
The management of motor neurone disease. J Neurol Neurosurg Psychiatry (2003) 1.06
Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience (2010) 1.06
Neurofibrillary tangles in dementia pugilistica are ubiquitinated. J Neurol Neurosurg Psychiatry (1991) 1.05
Cognitive change in ALS: a prospective study. Neurology (2005) 1.05
Anti-donor immune responses in prediction of transplant rejection. N Engl J Med (1976) 1.04
A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology (1998) 1.03
Inhibition of the immune response by 7S antibody mechanism and site of action. J Exp Med (1973) 1.03
Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study. Ann Neurol (1991) 1.02
Relationships between Lewy bodies and pale bodies in Parkinson's disease. Acta Neuropathol (1992) 1.01
Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol. J Neurol Neurosurg Psychiatry (1983) 1.01
The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinicopathological study. J Neurol Sci (1995) 1.01
SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis. J Neurol (2009) 1.00
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Eur J Neurol (2010) 1.00
The psychological impact of motor neurone disease. Psychol Med (1994) 0.99
Effects of respiratory activity on starvation survival of marine vibrios. Arch Microbiol (1990) 0.99
Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation. Ann Neurol (1997) 0.99
Predictors of psychological distress in carers of people with amyotrophic lateral sclerosis: a longitudinal study. Psychol Med (2006) 0.96
Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study. Neurology (1997) 0.96
Cortical function in progressive lower motor neuron disorders and amyotrophic lateral sclerosis: a comparative PET study. Neurology (1994) 0.95
p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction. Eur J Neurosci (2001) 0.95
Familial calcification of the basal ganglia: a case report and review of the literature. Psychol Med (1992) 0.94
Use of apomorphine in parkinsonian patients with neuropsychiatric complications to oral treatment. Parkinsonism Relat Disord (1997) 0.93
Patients' health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. J Neurol Sci (2001) 0.93
The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology (2006) 0.93
Longitudinal predictors of psychological distress and self-esteem in people with ALS. Neurology (2006) 0.91
Microdissection: a novel method for the study of intracellular inclusion bodies. J Pathol (1990) 0.91